Metadate ER
Compare with other ADHD Medications
Compare
| Metadate ER |
VS |
ADHD Medications |
|
|
Basic Information |
| Generic Name |
|
Methylphenidate |
42.9% ADHD Medications have methylphenidate
|
| Class |
|
Cns Stimulants |
85.7% ADHD Medications have CNS Stimulants |
| Prescription Generic Available |
|
Yes |
61.9% ADHD Medications have Prescription Generic Available
|
| Pregnancy cat. |
|
C(US) |
85.7% ADHD Medications have C(US) |
| Approved Age |
|
6 And Older |
85.7% ADHD Medications have 6 and older
|
| Legal Status |
|
Schedule Ii (us) |
|
| WADA Category |
|
S6 - Stimulants |
|
| Dependence Liability |
|
Moderate |
23.5% ADHD Medications have Moderate
|
| Excretion |
|
Urinary |
68.4% ADHD Medications have urinary |
| Possible Side Effects |
|
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
|
|
|
|
Dosage, Usage and Forms |
| Routes (of administration) |
|
Oral |
|
| Dosage |
|
10 Mg Q Am–30 Bid (max
60mg/day) |
|
| Maximum daily dose |
|
|
|
| Duration |
|
Intermediate-acting |
19% ADHD Medications have Intermediate-acting
|
| Duration - time |
|
6-8 H |
4.8% ADHD Medications have 6-8 h |
|
|
Chemical Data |
| Molecular mass (g/mol) |
|
269.77 G/mol |
|
| Half Life |
|
|
|
| Formula |
|
C14h19no2•hcl |
|
| Bioavailability |
|
|
|
| Protein binding |
|
|
|
| Metabolism |
|
Hepatic |
|